{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:23:50Z","timestamp":1792801430026,"version":"4.5.0"},"reference-count":55,"publisher":"National Institute for Health and Care Research","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment programme","doi-asserted-by":"publisher","award":["16\/31\/63"],"award-info":[{"award-number":["16\/31\/63"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["journalslibrary.nihr.ac.uk"],"crossmark-restriction":false},"short-container-title":["Health Technol Assess"],"abstract":"\n Background<\/jats:title>\n Functional motor disorder often causes persistent disabling symptoms that are associated with high healthcare costs. In recent years, specialist physiotherapy, informed by an understanding of functional motor disorder, has emerged as a promising treatment, but there is an absence of evidence of its effectiveness from large randomised controlled trials.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n We conducted a pragmatic, multicentre, randomised controlled trial, comparing specialist physiotherapy for functional motor disorder to treatment as usual, which was defined as community neurological physiotherapy. The primary outcome was the Short Form questionnaire-36 items Physical Functioning domain at 12 months (scale range 0\u2013100, with 100 indicating optimum health). The trial was powered to detect a 9-point difference in the primary outcome with 90% power at the 5% level of significance. Secondary domains of measurement included a patient perception of improvement, health-related quality of life, mobility, anxiety, depression and illness perception. We also completed a health economic analysis with the primary aim of calculating the mean incremental cost per quality-adjusted life-year over 12 months. In prespecified analysis plans, we excluded participants from the primary analysis if they were unable to receive their trial-allocated treatment due to COVID-19 lockdown restrictions. Sensitivity analysis explored the impact of this decision.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n Between 19 October 2018 and 31 January 2022, 355 adults with functional motor disorder were randomised (1\u2005:\u20051) to specialist physiotherapy (\n n<\/jats:italic>\n \u2005=\u2005179) and treatment as usual (\n n<\/jats:italic>\n \u2005=\u2005176). Eighty-nine participants were excluded due to COVID-19 disruptions. Retention for the primary analysis was 90% for both groups, leaving 241 participants in the primary analysis. At 12 months, there was no between-group difference in the primary outcome (adjusted mean difference 3.5, 95% confidence interval \u22122.3 to 9.3). However, several secondary outcomes favoured specialist physiotherapy, including the participant perception of improvement, Short Form questionnaire-36 items Mental Health domain, confidence in the diagnosis and two subscales (Personal Control and Illness Coherence) of the Revised Illness Perception Questionnaire. There were no differences in the remaining outcomes. At 6 months, the following outcome measures were significantly different, in favour of specialist physiotherapy: participant perception of improvement, the Short Form questionnaire-36 items Physical Role Limitations, Short Form questionnaire-36 items Social Functioning, Short Form questionnaire-36 items Mental Health, EuroQol-5 Dimensions five-level version utility score, confidence in the diagnosis and three subscales (Timeline Cyclical, Personal Control and Treatment Control) of the Revised Illness Perception Questionnaire. No outcomes significantly favoured treatment as usual. In the health economic analysis, the incremental cost per quality-adjusted life-year gained from a health and social care cost perspective was \u00a34133 with an 86% probability that specialist physiotherapy is cost-effective compared to treatment as usual at a cost-effectiveness threshold of \u00a320,000 per quality-adjusted life-year gained. There were no adverse events related to physiotherapy.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion<\/jats:title>\n Specialist physiotherapy was not superior to treatment as usual for the primary outcome, the Short Form questionnaire-36 items Physical Functioning domain at 12 months. However, a number of secondary outcome measures favoured specialist physiotherapy at 6 and 12 months. There is a high probability that specialist physiotherapy is cost-effective.<\/jats:p>\n <\/jats:sec>\n \n Limitations<\/jats:title>\n Participants in treatment as usual waited longer to start physiotherapy, which resulted in a shorter time between concluding treatment and completing the primary outcome. Most outcome measures, including the primary outcome, were participant reported, which may have been biased by perceptions of the randomised treatment allocation.<\/jats:p>\n <\/jats:sec>\n \n Future work<\/jats:title>\n Future work should identify or develop more suitable outcome measures for functional motor disorder research, explore who is most likely to benefit from specialist physiotherapy and identify alternative interventions for those unlikely to benefit from this treatment. Additional work is needed to adapt treatment to meet the needs of minority groups and young people.<\/jats:p>\n <\/jats:sec>\n \n Funding<\/jats:title>\n This synopsis presents independent research funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme as award number 16\/31\/63.<\/jats:p>\n <\/jats:sec>","DOI":"10.3310\/mkac9495","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T06:31:10Z","timestamp":1736836270000},"page":"1-28","update-policy":"https:\/\/doi.org\/10.3310\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":5,"title":["Outcomes of specialist physiotherapy for functional motor disorder: the Physio4FMD RCT"],"prefix":"10.3310","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6053-5670","authenticated-orcid":true,"given":"Glenn","family":"Nielsen","sequence":"first","affiliation":[{"name":"Neuroscience and Cell Biology Institute, St George\u2019s, University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9973-1131","authenticated-orcid":true,"given":"Louise","family":"Marston","sequence":"additional","affiliation":[{"name":"Department of Primary Care and Population Health, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7447-8934","authenticated-orcid":true,"given":"Rachael Maree","family":"Hunter","sequence":"additional","affiliation":[{"name":"PRIMENT Clinical Trials Unit, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7425-0964","authenticated-orcid":true,"given":"Alan","family":"Carson","sequence":"additional","affiliation":[{"name":"Centre for Clinical Brain Sciences, Royal Infirmary of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9387-3035","authenticated-orcid":true,"given":"Laura H","family":"Goldstein","sequence":"additional","affiliation":[{"name":"Department of Psychology, Institute of Psychiatry, Psychology & Neuroscience, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9529-2420","authenticated-orcid":true,"given":"Kate","family":"Holt","sequence":"additional","affiliation":[{"name":"Neuroscience and Cell Biology Institute, St George\u2019s, University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-0917-860X","authenticated-orcid":true,"given":"Teresa C","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Primary Care and Population Health, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9479-8599","authenticated-orcid":true,"given":"Marie","family":"Le Novere","sequence":"additional","affiliation":[{"name":"PRIMENT Clinical Trials Unit, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2037-4902","authenticated-orcid":true,"given":"Jonathan","family":"Marsden","sequence":"additional","affiliation":[{"name":"School of Health Professions, Faculty of Health, University of Plymouth, Plymouth, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2146-9628","authenticated-orcid":true,"given":"Irwin","family":"Nazareth","sequence":"additional","affiliation":[{"name":"Department of Primary Care and Population Health, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4267-1609","authenticated-orcid":true,"given":"Hayley","family":"Noble","sequence":"additional","affiliation":[{"name":"Neuroscience and Cell Biology Institute, St George\u2019s, University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4104-6705","authenticated-orcid":true,"given":"Markus","family":"Reuber","sequence":"additional","affiliation":[{"name":"Academic Neurology Unit, University of Sheffield, Royal Hallamshire, Sheffield, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9829-8092","authenticated-orcid":true,"given":"Jon","family":"Stone","sequence":"additional","affiliation":[{"name":"Centre for Clinical Brain Sciences, Royal Infirmary of Edinburgh, Edinburgh, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2817-5219","authenticated-orcid":true,"given":"Ann-Marie","family":"Strudwick","sequence":"additional","affiliation":[{"name":"Neuroscience and Cell Biology Institute, St George\u2019s, University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1902-8332","authenticated-orcid":true,"given":"Beatriz Santana","family":"Suarez","sequence":"additional","affiliation":[{"name":"Neuroscience and Cell Biology Institute, St George\u2019s, University of London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8283-9015","authenticated-orcid":true,"given":"Mark J","family":"Edwards","sequence":"additional","affiliation":[{"name":"Department of Basic and Clinical Neuroscience, Institute of Psychiatry, Psychology and Neuroscience, King\u2019s College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"6221","published-online":{"date-parts":[[2025,7]]},"reference":[{"key":"key2025080411545900_ref1-bib1","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.clineuro.2010.05.011","article-title":"Who is referred to neurology clinics?: the diagnoses made in 3781 new patients","volume":"112","author":"Stone","year":"2010","journal-title":"Clin Neurol Neurosurg"},{"key":"key2025080411545900_ref2-bib2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1136\/jnnp-2015-311114","article-title":"Incidence and outcome of functional stroke mimics admitted to a hyperacute stroke unit","volume":"88","author":"Gargalas","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key2025080411545900_ref3-bib3","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1474-4422(21)00422-1","article-title":"Functional neurological disorder: new subtypes and shared mechanisms","volume":"21","author":"Hallett","year":"2022","journal-title":"Lancet Neurol"},{"key":"key2025080411545900_ref4-bib4","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/mdc3.13077","article-title":"Clinical correlates of functional motor disorders: an Italian multicenter study","volume":"7","author":"Tinazzi","year":"2020","journal-title":"Mov Disord Clin Pract"},{"key":"key2025080411545900_ref5-bib5","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1111\/ene.15018","article-title":"International online survey of 1048 individuals with functional neurological disorder","volume":"28","author":"Butler","year":"2021","journal-title":"Eur J Neurol"},{"key":"key2025080411545900_ref6-bib6","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1136\/jnnp-2013-305321","article-title":"The prognosis of functional (psychogenic) motor symptoms: a systematic review","volume":"85","author":"Gelauff","year":"2014","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key2025080411545900_ref7-bib7","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1093\/brain\/awz138","article-title":"The prognosis of functional limb weakness: a 14-year case-control study","volume":"142","author":"Gelauff","year":"2019","journal-title":"Brain"},{"key":"key2025080411545900_ref8-bib8","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1136\/jnnp.2010.220640","article-title":"Disability, distress and unemployment in neurology outpatients with symptoms \u2018unexplained by organic disease\u2019","volume":"82","author":"Carson","year":"2011","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key2025080411545900_ref9-bib9","first-page":"e202","article-title":"Economic cost of functional neurologic disorders: a systematic review","volume":"101","author":"O\u2019Mahony","year":"2023","journal-title":"Neurology"},{"key":"key2025080411545900_ref10-bib10","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1136\/jnnp-2020-323953","article-title":"Decade of progress in motor functional neurological disorder: continuing the momentum","volume":"92","author":"Perez","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key2025080411545900_ref11-bib11","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1093\/brain\/aws129","article-title":"A Bayesian account of \u2018hysteria\u2019","volume":"135","author":"Edwards","year":"2012","journal-title":"Brain"},{"key":"key2025080411545900_ref12-bib12","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1093\/brain\/awac204","article-title":"A new science of emotion: implications for functional neurological disorder","volume":"145","author":"Jungilligens","year":"2022","journal-title":"Brain"},{"key":"key2025080411545900_ref13-bib13","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1136\/bmj.2.462.483","article-title":"Remarks on paralysis and other disorders of motion and sensation dependent on idea","volume":"2","author":"Reynolds","year":"1869","journal-title":"BMJ"},{"key":"key2025080411545900_ref14-bib14","first-page":"198","article-title":"An approach to the treatment of abnormal ambulation resulting from conversion reaction","volume":"51","author":"Trieschmann","year":"1970","journal-title":"Arch Phys Med Rehabil"},{"key":"key2025080411545900_ref15-bib15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.jpsychores.2013.05.006","article-title":"Physiotherapy for functional (psychogenic) motor symptoms: a systematic review","volume":"75","author":"Nielsen","year":"2013","journal-title":"J Psychosom Res"},{"key":"key2025080411545900_ref16-bib16","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2340\/16501977-1246","article-title":"Psychogenic gait disorder: a randomized controlled trial of physical rehabilitation with one-year follow-up","volume":"46","author":"Jordbru","year":"2014","journal-title":"J Rehabil Med"},{"key":"key2025080411545900_ref17-bib17","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.parkreldis.2011.10.011","article-title":"Functional movement disorders: successful treatment with a physical therapy rehabilitation protocol","volume":"18","author":"Czarnecki","year":"2012","journal-title":"Parkinsonism Relat Disord"},{"key":"key2025080411545900_ref18-bib18","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1136\/jnnp-2014-309255","article-title":"Physiotherapy for functional motor disorders: a consensus recommendation","volume":"86","author":"Nielsen","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key2025080411545900_ref19-bib19","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1007\/s00415-014-7631-1","article-title":"Outcomes of a 5-day physiotherapy programme for functional (psychogenic) motor disorders","volume":"262","author":"Nielsen","year":"2015","journal-title":"J Neurol"},{"key":"key2025080411545900_ref20-bib20","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1136\/jnnp-2016-314408","article-title":"Randomised feasibility study of physiotherapy for patients with functional motor symptoms","volume":"88","author":"Nielsen","year":"2017","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key2025080411545900_ref21-bib21","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1741-7015-8-18","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"8","author":"Schulz","year":"2010","journal-title":"BMC Med"},{"key":"key2025080411545900_ref22-bib22","first-page":"100063","article-title":"Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations","volume":"3","author":"Husereau","year":"2022","journal-title":"MDM Policy Pract"},{"key":"key2025080411545900_ref23-bib23","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s12883-019-1461-9","article-title":"Physio4FMD: protocol for a multicentre randomised controlled trial of specialist physiotherapy for functional motor disorder","volume":"19","author":"Nielsen","year":"2019","journal-title":"BMC Neurol"},{"key":"key2025080411545900_ref24-bib24","doi-asserted-by":"crossref","first-page":"101124","DOI":"10.1016\/j.conctc.2023.101124","article-title":"COVID-19 and the Physio4FMD trial: impact, mitigating strategies and analysis plans","volume":"33","author":"Marston","year":"2023","journal-title":"Contemp Clin Trials Commun"},{"key":"key2025080411545900_ref25-bib25","volume-title":"Physio4FMD Programme Workbook 2.0","author":"Nielsen","year":"2023"},{"key":"key2025080411545900_ref26-bib26","volume-title":"Physio4FMD Intervention Manual","author":"Nielsen","year":"2023"},{"key":"key2025080411545900_ref27-bib27","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/S1474-4422(24)00135-2","article-title":"Specialist physiotherapy for functional motor disorder in England and Scotland (Physio4FMD): a pragmatic, multicentre, phase 3 randomised controlled trial","volume":"23","author":"Nielsen","year":"2024","journal-title":"Lancet Neurol"},{"key":"key2025080411545900_ref28-bib28","doi-asserted-by":"crossref","first-page":"e200465","DOI":"10.1212\/CPJ.0000000000200465","article-title":"Cost-utility of specialist physiotherapy for functional motor disorder (Physio4FMD): economic analysis of a pragmatic randomised control trial","volume":"15","author":"Hunter","year":"2025","journal-title":"Neurol Clin Pract"},{"key":"key2025080411545900_ref29-bib29","doi-asserted-by":"crossref","first-page":"112056","DOI":"10.1016\/j.jpsychores.2025.112056","article-title":"Which factors predict outcome from specialist physiotherapy for functional motor disorder? Prognostic modelling of the Physio4FMD intervention","volume":"190","author":"Nielsen","year":"2025","journal-title":"Journal of Psychosomatic Research"},{"key":"key2025080411545900_ref30-bib30","volume-title":"Animation Plain English Summary of the Physio4FMD RCT: A Randomised Trial of Specialist Physiotherapy for Functional Motor Disorder","author":"Science Animated with the Physio4FMD Collaborative Group","year":"2024"},{"key":"key2025080411545900_ref31-bib31","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1136\/jnnp-2019-322180","article-title":"Outcome measurement in functional neurological disorder: a systematic review and recommendations","volume":"91","author":"Pick","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key2025080411545900_ref32-bib32","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1093\/fampra\/10.1.76","article-title":"The nominal group technique: a research tool for general practice?","volume":"10","author":"Gallagher","year":"1993","journal-title":"Fam Pract"},{"key":"key2025080411545900_ref33-bib33","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1176\/appi.neuropsych.19060128","article-title":"Outcome measures for functional neurological disorder: a review of the theoretical complexities","volume":"32","author":"Nicholson","year":"2020","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"key2025080411545900_ref34-bib34","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1007\/s00415-014-7495-4","article-title":"Multidisciplinary treatment for functional neurological symptoms: a prospective study","volume":"261","author":"Demartini","year":"2014","journal-title":"J Neurol"},{"key":"key2025080411545900_ref35-bib35","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1136\/jnnp-2013-305716","article-title":"Specialist inpatient treatment for severe motor conversion disorder: a retrospective comparative study","volume":"85","author":"McCormack","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key2025080411545900_ref36-bib36","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1136\/jnnp-2019-321926","article-title":"Systematic review of psychotherapy for adults with functional neurological disorder","volume":"92","author":"Gutkin","year":"2020","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key2025080411545900_ref37-bib37","volume-title":"Twitter Dissemination of Animation of Plain Language Summary of the Physio4FMD RCT","author":"Nielsen","year":"2024"},{"key":"key2025080411545900_ref38-bib38","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1080\/09638288.2018.1550685","article-title":"A qualitative study of the experiences and perceptions of patients with functional motor disorder","volume":"42","author":"Nielsen","year":"2019","journal-title":"Disabil Rehabil"},{"key":"key2025080411545900_ref39-bib39","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.pec.2004.02.010","article-title":"Understanding the narratives of people who live with medically unexplained illness","volume":"56","author":"Nettleton","year":"2005","journal-title":"Patient Educ Couns"},{"key":"key2025080411545900_ref40-bib40","volume-title":"Functional Neurologic Disorders, Vol 139 of the Handbook of Clinical Neurology Series","author":"Carson","year":"2016"},{"key":"key2025080411545900_ref41-bib41","article-title":"Functional neurological disorder is a feminist issue","volume":"1","author":"Mcloughlin","year":"2023","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"key2025080411545900_ref42-bib42","volume-title":"Ethnic Group, England and Wales: Census 2021","author":"Office for National Statistics (ONS)","year":"n.d"},{"key":"key2025080411545900_ref43-bib43","volume-title":"Ethnicity | Scotland\u2019s Census","year":"n.d"},{"key":"key2025080411545900_ref44-bib44","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1038\/s41582-022-00765-z","article-title":"Why functional neurological disorder is not feigning or malingering","volume":"19","author":"Edwards","year":"2023","journal-title":"Nat Rev Neurol"},{"key":"key2025080411545900_ref45-bib45","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1177\/0957154X9901003901","article-title":"Hysteria: a cross-cultural comparison of its origins and history","volume":"10","author":"Ng","year":"1999","journal-title":"Hist Psychiatry"},{"key":"key2025080411545900_ref46-bib46","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1521\/psyc.2011.74.3.187","article-title":"Culture and conversion disorder: implications for DSM-5","volume":"74","author":"Brown","year":"2011","journal-title":"Psychiatry"},{"key":"key2025080411545900_ref47-bib47","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/PSY.0000000000000563","article-title":"Functional stroke mimics: Incidence and characteristics at a primary stroke center in the middle east","volume":"80","author":"Wilkins","year":"2018","journal-title":"Psychosom Med"},{"key":"key2025080411545900_ref48-bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12888-015-0484-z","article-title":"Overcoming barriers to recruiting ethnic minorities to mental health research: a typology of recruitment strategies","volume":"15","author":"Waheed","year":"2015","journal-title":"BMC Psychiatry"},{"key":"key2025080411545900_ref49-bib49","volume-title":"Freedom of Information Project Aimed to Explore Issues Reported by NHS Clinicians and the FND Community Regarding Accesses to Treatment for People with FND","author":"FND Hope UK","year":"2019"},{"key":"key2025080411545900_ref50-bib50","volume-title":"Project Information | Rehabilitation for Chronic Neurological Disorders Including Acquired Brain Injury | Guidance [GID-NG10181]","author":"National Institute for Health and Care Excellence (NICE)","year":"n.d"},{"key":"key2025080411545900_ref51-bib51","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1002\/mds.27302","article-title":"Short- and long-term cost and utilization of health care resources in Parkinson\u2019s disease in the UK","volume":"33","author":"Weir","year":"2018","journal-title":"Mov Disord"},{"key":"key2025080411545900_ref52-bib52","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1177\/1352458517708687","article-title":"New insights into the burden and costs of multiple sclerosis in Europe: results for the United Kingdom","volume":"23","author":"Thompson","year":"2017","journal-title":"Mult Scler"},{"key":"key2025080411545900_ref53-bib53","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1002\/mdc3.12475","article-title":"A simplified version of the Psychogenic Movement Disorders Rating Scale: the Simplified Functional Movement Disorders Rating Scale (S-FMDRS)","volume":"4","author":"Nielsen","year":"2017","journal-title":"Mov Disord Clin Pract"},{"key":"key2025080411545900_ref55-bib55","first-page":"33","article-title":"Outcome measures for functional neurological (conversion) disorder: a review of the theoretical complexities","volume":"32","author":"Nicholson","year":"2020","journal-title":"J Neurol Clin Neurosci"},{"key":"key2025080411545900_ref56-bib56","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/dmcn.15538","article-title":"Functional neurological disorder in children and young people: incidence, clinical features, and prognosis","volume":"65","author":"Yong","year":"2023","journal-title":"Dev Med Child Neurol"}],"container-title":["Health Technology Assessment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2048504","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/sites\/journalslibrary\/files\/journal_data\/MKAC9495\/MKAC9495.xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/njl-admin.nihr.ac.uk\/document\/download\/2048504","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,4]],"date-time":"2025-08-04T06:35:33Z","timestamp":1754289333000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.journalslibrary.nihr.ac.uk\/hta\/MKAC9495"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":55,"alternative-id":["10.3310\/MKAC9495"],"URL":"https:\/\/doi.org\/10.3310\/mkac9495","relation":{},"ISSN":["2046-4924"],"issn-type":[{"value":"2046-4924","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"This content has been made freely available to all.","name":"free","label":"Free to read"},{"value":"05-2018","name":"contractual_start_date","label":"contractual_start_date","group":{"name":"article_history","label":"Article History"}},{"value":"04-2024","name":"editorial_review_begun","label":"editorial review begun","group":{"name":"article_history","label":"Article History"}},{"value":"02-2025","name":"accepted_for_publication","label":"Accepted for publication","group":{"name":"article_history","label":"Article History"}}]}}